<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">Rashes</z:e> and <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> are disconcerting adverse effects associated with carbamazepine therapy </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">Rashes</z:e> are quite common, as are mild <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e>, such as mild <z:hpo ids='HP_0001882'>leukopenias</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Fortunately, severe <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> and <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> are rare </plain></SENT>
<SENT sid="3" pm="."><plain>There are few reports on the relationship between carbamazepine-induced <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> and <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e>, including a prospective study in which <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> appeared concomitantly with <z:hpo ids='HP_0001882'>leukopenia</z:hpo> and/or <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in 10 patients, two case reports in which simultaneous <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> and <z:mp ids='MP_0000334'>agranulocytosis</z:mp> occurred, and two case reports in which <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> served as harbingers of fatal <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>CASE REPORTS: We report two cases of concomitant <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> and <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> in geriatric psychiatry patients receiving carbamazepine therapy for <z:hpo ids='HP_0007302'>bipolar disorder</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>One patient was found to have a severe <z:hpo ids='HP_0001882'>leukopenia</z:hpo> within several days after <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The other patient was discovered to have a severe <z:hpo ids='HP_0001882'>leukopenia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> within about a month after <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>DISCUSSION: Current hematologic monitoring guidelines for carbamazepine rely heavily on the recognition of signs and symptoms of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> by clinicians and patients </plain></SENT>
<SENT sid="8" pm="."><plain>We believe that our cases support the suggestion that patients who develop <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> receive more vigilant monitoring of the complete blood count, should carbamazepine therapy by continued </plain></SENT>
<SENT sid="9" pm="."><plain>Given the currently available case reports and the fact that the incidence of drug-induced <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> increases with advanced age, this recommendation may be particularly relevant for geriatric patients </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Further study is required to establish whether carbamazepine-induced concomitant <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e> and <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> are valid associations insofar as monitoring is concerned </plain></SENT>
</text></document>